A Phase 1b Study of the NLRP3 Inhibitor VENT-02 in Patients With Mild to Moderate Parkinson's Disease

Clinical trial NCT06822517 · TERMINATED

Trial details

NCT number: NCT06822517
Sponsor: Ventus Therapeutics U.S., Inc.
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Parkinson Disease

Start date: 2025-03-05
Primary completion: 2025-10-09
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.